Literature DB >> 23921742

Huntington's disease: easing the NMDAR traffic jam.

Anthony Daggett1, X William Yang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23921742     DOI： 10.1038/nm.3283

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

Review 1.  Glutamate receptor dynamics in dendritic microdomains.

Authors:  Thomas M Newpher; Michael D Ehlers
Journal:  Neuron       Date:  2008-05-22       Impact factor: 17.173

Review 2.  Diversity in NMDA receptor composition: many regulators, many consequences.

Authors:  Antonio Sanz-Clemente; Roger A Nicoll; Katherine W Roche
Journal:  Neuroscientist       Date:  2012-02-17       Impact factor: 7.519

Review 3.  Huntington's disease: from molecular pathogenesis to clinical treatment.

Authors:  Christopher A Ross; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

Review 4.  Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.

Authors:  L A Raymond; V M André; C Cepeda; C M Gladding; A J Milnerwood; M S Levine
Journal:  Neuroscience       Date:  2011-08-27       Impact factor: 3.590

5.  Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice.

Authors:  Austen J Milnerwood; Clare M Gladding; Mahmoud A Pouladi; Alexandra M Kaufman; Rochelle M Hines; Jamie D Boyd; Rebecca W Y Ko; Oana C Vasuta; Rona K Graham; Michael R Hayden; Timothy H Murphy; Lynn A Raymond
Journal:  Neuron       Date:  2010-01-28       Impact factor: 17.173

6.  Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A.

Authors:  S Das; Y F Sasaki; T Rothe; L S Premkumar; M Takasu; J E Crandall; P Dikkes; D A Conner; P V Rayudu; W Cheung; H S Chen; S A Lipton; N Nakanishi
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

7.  PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains.

Authors:  Jan Modregger; Nicholas A DiProspero; Vinod Charles; Danilo A Tagle; Markus Plomann
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

8.  Network organization of the huntingtin proteomic interactome in mammalian brain.

Authors:  Dyna I Shirasaki; Erin R Greiner; Ismael Al-Ramahi; Michelle Gray; Pinmanee Boontheung; Daniel H Geschwind; Juan Botas; Giovanni Coppola; Steve Horvath; Joseph A Loo; X William Yang
Journal:  Neuron       Date:  2012-07-12       Impact factor: 17.173

9.  Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models.

Authors:  Sonia Marco; Albert Giralt; Milos M Petrovic; Mahmoud A Pouladi; Rebeca Martínez-Turrillas; José Martínez-Hernández; Linda S Kaltenbach; Jesús Torres-Peraza; Rona K Graham; Masahiko Watanabe; Rafael Luján; Nobuki Nakanishi; Stuart A Lipton; Donald C Lo; Michael R Hayden; Jordi Alberch; John F Wesseling; Isabel Pérez-Otaño
Journal:  Nat Med       Date:  2013-07-14       Impact factor: 53.440

10.  Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin.

Authors:  Shu-ichi Okamoto; Mahmoud A Pouladi; Maria Talantova; Dongdong Yao; Peng Xia; Dagmar E Ehrnhoefer; Rameez Zaidi; Arjay Clemente; Marcus Kaul; Rona K Graham; Dongxian Zhang; H-S Vincent Chen; Gary Tong; Michael R Hayden; Stuart A Lipton
Journal:  Nat Med       Date:  2009-11-15       Impact factor: 53.440
View more
  1 in total

Review 1.  Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.

Authors:  Bettina Balint; Angela Vincent; Hans-Michael Meinck; Sarosh R Irani; Kailash P Bhatia
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.